Biotech
Arkin raises $100m for early-stage biotech fund
The main investors in Arkin Bio Ventures III together with Arkin Capital are Israeli institutional investors including Phoenix Finance, Clal Insurance, and Amitim pension fund
Israel's biotech moment: How science, data, and geopolitics are converging - opinion
EU Council and Parliament reach agreement to overhaul drug rules, speed patient access
Midlife weight loss shows metabolic benefits but sparks brain inflammation in BGU - study
Biotech between worlds: Jacob Licht's aliyah story - interview
A better question might be: For a couple who fell in love with Israel as teenagers, why did it take us so long to make aliyah?
Israeli woman's vision restored in world's first-ever 3D-printed cornea implant
The new Israeli technology allows for the creation of hundreds of cornea implants from a single donor sample, offering a scalable solution.
Jerusalem surges ahead: Aspiring to become Israel’s biotech capital
Jerusalem's biotech sector grows with $1.7B in investments and 150 companies. In June, the city will host the international medical hackathon MinDstart.
Jerusalem as our biotech capital: The city’s ascent as an innovation hub - opinion
Jerusalem's transformation is the outcome of long-term strategic policy, targeted public investment, and a thriving academic ecosystem.
Is former truck mechanic Tim Friede may be key in creating anti-venom biotech
Friede's subjected himself to over 200 snake bites.
Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors
Dolsten brings decades of pharmaceutical leadership to advance AI-driven drug discovery.
MNDL Bio wins award for the most innovative biotech solution in the Middle East
The startup company MNDL Bio has been named the winner of the Most Innovative Biotech Solution in the Middle East award.
Phage virus discovered at Hebrew University named after fallen soldier
Phages are viruses that precisely target and kill bacteria, which can offer “a potential solution to the growing crisis of antibiotic resistance.”
The unique challenges integrating AI into biotechnology - opinion
According to Start-Up Nation Central (SNC), AI represents about 30% of Israel’s start-ups and attracts nearly half of total company funding.
Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
Aardvark tech track gives gap year students an opportunity to take part in the start up nation
The Inside Israeli Innovation Podcast with guest hosts Ellie Esquenazi and Corey Tusak: Season 2, Episode 34.
